<DOC>
	<DOCNO>NCT02058940</DOCNO>
	<brief_summary>The purpose study assess feasibility exenatide infusion treatment high blood sugar follow acute brain injury .</brief_summary>
	<brief_title>Intravenous Exenatide Patients With Acute Brain Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Adults ≥18 year Acute brain injury result admission Neurosciences Intensive Care Unit anticipate length stay &gt; 48 hour Two Blood glucose concentration &gt; 150 mg/dL ≤300 mg/dL Informed consent obtain via proxy Pregnant ( verified urine serum pregnancy test within 24 hour initiation infusion ) lactating female Type 1 diabetes mellitus History pancreatitis risk factor acute pancreatitis ( i.e ethanol abuse , gall stone ) Renal insufficiency define creatinine clearance ( CrCL ) &lt; 45 mL/min Known history gastroparesis History surgery stomach , esophagus duodenum Diabetic Ketoacidosis Hyperosmolar Hyperglycemic Nonketotic Syndrome Concurrent steroid use plan postoperative steroid use History organ transplantation Brain death suspect imminent brain death within next 72 hour Refractory intracranial hypertension define intracranial pressure ( ICP ) &gt; 25 mmHg great 15 minute refractory medical intervention Currently enrol another investigational drug device protocol Insulin infusion within 3 hour study drug administration confirm long acting insulin sulfonylurea use prior admission within 24 hour study drug administration Known allergy exenatide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>